Mather Group
TMDX icon

Mather Group’s Transmedics TMDX Stock Holding History

Mather Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.5K Buy
42
+25
+147% +$2.06K ﹤0.01% 1904
2026
Q2 		$1.13K Hold
17
– – ﹤0.01% 1789
2026
Q1 		$1.69K Buy
+17
New +$2.22K ﹤0.01% 1719
2025
Q1 		– Sell
-16
Closed -$998 – 1860
2024
Q4 		$998 Hold
16
– – ﹤0.01% 1614
2024
Q3 		$2.51K Buy
+16
New +$2.46K ﹤0.01% 1432

Other funds holding TMDX

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Zevenbergen Capital Investments
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Taylor Frigon Capital Management
Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Mather Group's TMDX Position: Q3 2026 in Review

Mather Group increased its Transmedics (TMDX) stake by 147% in Q3 2026, buying an estimated $2.06K and bringing the position to 42 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Mather Group first reported a position in TMDX in Q3 2024 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Mather Group held 42 shares of Transmedics worth $3.5K as of Q3 2026.
  • Mather Group bought 25 Transmedics shares in Q3 2026, an estimated $2.06K.
  • Transmedics made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1904 holding.
  • Mather Group first reported a position in Transmedics in Q3 2024 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.